Alterations in metabolic fate of glucose in the liver of diabetic animals.
D000332:Aerobiosis; D000693:Anaerobiosis; D000818:Animals; D002952:Citric Acid Cycle; D003920:Diabetes Mellitus / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D005227:Fatty Acids / Q000096:biosynthesis; D005943:Gluconeogenesis; D005947:Glucose / Q000378:metabolism*; D005958:Glucosephosphates / Q000096:biosynthesis; D006019:Glycolysis; D007328:Insulin / Q000494:pharmacology / Q000627:therapeutic use; D007330:Insulin Antibodies; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008112:Liver Glycogen / Q000096:biosynthesis; D010180:Pancreatectomy; D010428:Pentosephosphates / Q000378:metabolism; D051381:Rats; D013311:Streptozocin
D005227:Fatty Acids; D005958:Glucosephosphates; D007328:Insulin; D007330:Insulin Antibodies; D008112:Liver Glycogen; D010428:Pentosephosphates; D013311:Streptozocin; D005947:Glucose